BioPorto A/S (THOXF)
OTCMKTS
· Delayed Price · Currency is USD
0.2880
+0.0580 (25.22%)
At close: Jun 26, 2024
BioPorto Employees
BioPorto had 48 employees as of December 31, 2024. The number of employees increased by 19 or 65.52% compared to the previous year.
Employees
48
Change (1Y)
19
Growth (1Y)
65.52%
Revenue / Employee
$104,819
Profits / Employee
-$197,368
Market Cap
103.98M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Glass House Brands | 374 |
Elite Pharmaceuticals | 64 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Longduoduo Company | 49 |
BioPorto News
- 5 weeks ago - Notice convening the Annual General Meeting in BioPorto A/S - GlobeNewsWire
- 5 weeks ago - BioPorto announces the Annual Report for 2024 - GlobeNewsWire
- 5 weeks ago - BioPorto announces guidance for 2025 and aspirations for 2026 towards 2029 - GlobeNewsWire
- 7 weeks ago - BioPorto A/S announces Jens Due Olsen as a Board of Directors candidate intending to appoint Jens Due Olsen as Chair, along with updates on other candidates - GlobeNewsWire
- 2 months ago - Strengthening of Investor Focus – BioPorto enters Market Maker Agreement with Danske Bank & appoints New Head of Investor Relations - GlobeNewsWire
- 3 months ago - BioPorto A/S appoints new interim Chairman of the Board - GlobeNewsWire
- 3 months ago - BioPorto announces the publication of urinary NGAL reference ranges in healthy adult and pediatric individuals - GlobeNewsWire
- 4 months ago - BioPorto commences process to appoint new Chair of the Board of Directors - GlobeNewsWire